Imagine being prescribed a medication that costs $6,000 a month. That’s a far cry from a $30 copay – and it’s an unfortunate reality for people battling complex and rare conditions such as Crohn’s disease, rheumatoid arthritis, cancer, and multiple sclerosis.
Alternate funding means exploring non-traditional avenues to help pay for high-cost medications, such as patient assistance programs, manufacturer copay assistance, international sourcing, and 340b programs.
Unlike other PBMs that offer one or two options, IPM uses proprietary clinical and solution-driven expertise to match the right solutions to an employer’s benefit strategy. Our approach is unique because we integrate these efforts, working each claim individually to identify the best option for each member.
We recognize that what’s doable for one patient may not be doable for another. And the same can be said about the employer. Each alternate funding option has pros and cons that differ from patient to patient, and employer to employer, which makes having multiple options available an ideal approach.
A high-cost drug is any medication that ranges $250 to $350 a month or more. IPM’s proprietary algorithm identifies claims that fall into this range and assists members with gathering paperwork, filling out applications, and coordinating with providers.
Our alternate funding program can save clients up to 75% on high-cost claims. Fill out the form below for more information!
Alternative drug recommendation results in saving over $79,500 for a patient’s treatment.
A therapeutic interchange saves $71,000 for a single patient treatment.
Contact us if you have any questions.